UNSPSC 85816314: Introduction of blood brain barrier disruption substance into peripheral vein, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of blood brain barrier disruption substance into peripheral vein, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E033GN

UNSPSC 85816314, Introduction of blood brain barrier disruption substance into peripheral vein, percutaneous approach, is a Commodity code that shows a substantial mismatch between its clinical-procedure nominal scope and actual state and local procurement activity. The recent opportunities tagged under this code span telehealth urgent care, nursing home operations, occupational health services, cancer screening, employee wellness platforms, EMS staffing, psychiatric evaluation, and opioid use disorder treatment—none of which involve blood-brain-barrier disruption procedures or intravenous pharmaceutical administration. State and local governments are not procuring this specific medical procedure or the reagents required to perform it; instead, they are purchasing a far broader array of behavioral health, occupational health, emergency medical, and preventive health services through health departments, counties, cities, school districts, and special authorities across California, Georgia, Nevada, Oregon, Colorado, Florida, Texas, Arizona, Illinois, Kansas, New York, and other jurisdictions.

The code shows little relevant recent activity aligned with its stated clinical scope. If your firm specializes in blood-brain-barrier disruption substances, pharmaceuticals, or clinical procedures in that family, this code is not currently a productive vector for state and local opportunity pursuit. The mismatch appears to reflect either a data classification artifact or an isolated historical tagging rather than active market demand. Monitor the code for correction or clarification, but do not prioritize business development effort here without evidence that state and local procurement offices are actually buying this specific service or product category.